aldosterone has been researched along with Anterior Choroidal Artery Infarction in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aldosterone is a risk factor for stroke, and the literature suggests it may play a role in increasing the expression of the receptor for EGF (EGFR)." | 5.31 | Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats. ( Dorrance, AM; Grekin, R; Osborn, HL; Webb, RC, 2001) |
| "To clarify the effects of zolpidem, a gamma-aminobutyric acid (GABA)(A) receptor agonist, on bladder function, and urine production, we investigated the effects of zolpidem administration on bladder overactivity induced by cerebral infarction (CI) and on urine excretion increased by water overloading in Wistar rats." | 3.76 | Zolpidem increases bladder capacity and decreases urine excretion in rats. ( Matsuta, Y; Ohtake, A; Sasamata, M; Suzuki, M; Watanabe, M; Yanai-Inamura, H; Yokoyama, O, 2010) |
| "Aldosterone is a risk factor for stroke, and the literature suggests it may play a role in increasing the expression of the receptor for EGF (EGFR)." | 1.31 | Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats. ( Dorrance, AM; Grekin, R; Osborn, HL; Webb, RC, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yokoyama, O | 1 |
| Matsuta, Y | 1 |
| Yanai-Inamura, H | 1 |
| Watanabe, M | 1 |
| Ohtake, A | 1 |
| Suzuki, M | 1 |
| Sasamata, M | 1 |
| Dorrance, AM | 1 |
| Osborn, HL | 1 |
| Grekin, R | 1 |
| Webb, RC | 1 |
2 other studies available for aldosterone and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Zolpidem increases bladder capacity and decreases urine excretion in rats.
Topics: Aldosterone; Animals; Bicuculline; Cerebral Infarction; Disease Models, Animal; Dose-Response Relati | 2010 |
Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats.
Topics: Aldosterone; Animals; Aorta; Basal Ganglia; Blood Pressure; Body Weight; Cerebral Cortex; Cerebral I | 2001 |